ocr: Figure 3 Bone mineral density - AP Lumbar spine Least squares means of percentage change from baseline All randomized patients with at least one post-baseline assessment available with last post-baseline observation carried forward / 6 5 4 3 2 1 -1 -2 -3 Week 26 Week 52 Week 78 Week 104 Treatment duration Vivelle 0.1mg/day - - : Vivelle 0.05 mg/day - * - - Vivelle 0.0375 mg/day * -Vivelle 0.025 mg/day * Placebo
